|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 994 KRW | +8.52% |
|
-.--% | -80.70% |
| Mar. 29 | CANARIABIO Inc.(KOSDAQ:A016790) dropped from S&P Global BMI Index | CI |
| Jan. 24 | Quest PharmaTech Inc. Says Oregovomab Phase III Clinical Study Fails Futility Analysis | MT |
On December 19, 2022, CANARIABIO Inc. closed the transaction.
| 1st Jan change | Capi. | |
|---|---|---|
| -80.70% | 137M | |
| +12.98% | 11.64B | |
| +0.32% | 5.85B | |
| +5.47% | 5.42B | |
| +3.06% | 4.53B | |
| -19.30% | 2.74B | |
| -18.80% | 1.2B | |
| -16.85% | 965M | |
| -11.21% | 946M | |
| +23.98% | 838M |
CANARIABIO INC. 